Joel Habener: Difference between revisions
Content deleted Content added
Kj cheetham (talk | contribs) Added {{Cleanup bare URLs}} tag (TW) |
Shinkolobwe (talk | contribs) Wikilink |
||
| (25 intermediate revisions by 16 users not shown) | |||
| Line 1: | Line 1: | ||
{{Short description|American endocrinologist}} |
|||
{{Cleanup bare URLs|date=August 2020}} |
|||
{{Infobox person/Wikidata|fetchwikidata=ALL}} |
|||
'''Joel Habener''' is a Professor of Medicine at [[Harvard Medical School]] who has done fundamental studies on elucidating the role of [[incretin]] hormones such as [[Glucagon-like peptide-1|Glucagon-like peptide-1 (GLP-1)]] and [[Glucagon-like peptide-2|Glucagon-like peptide-2 (GLP-2)]]. For his discoveries, he was awarded the 2020 [[Warren Alpert Foundation Prize]] along with [[Daniel J. Drucker|Daniel Drucker]] and Jens Juul Holst.<ref>https://warrenalpert.org/prize-recipients</ref> He was elected to the [[National Academy of Sciences]] in 2020.<ref>http://www.nasonline.org/news-and-multimedia/news/2020-nas-election.html</ref> |
|||
'''Joel Habener''' is a Professor of Medicine at [[Harvard Medical School]]. |
|||
Habener worked with [[Svetlana Mojsov]] on elucidating the role of [[incretin]] [[hormone]]s such as [[Glucagon-like peptide-1|glucagon-like peptide-1 (GLP-1)]] and [[Glucagon-like peptide-2|glucagon-like peptide-2 (GLP-2)]]. Habener received credit for the work on hormones when Mosjov was not credited.<ref>{{Cite web |last=Molteni |first=Megan |last2=Chen |first2=Elaine |date=27 September 2023 |title=The Ozempic revolution is rooted in the work of Svetlana Mojsov, yet she’s been edged out of the story |url=https://www.statnews.com/2023/09/27/weight-loss-obesity-glp1-svetlana-mojsov/ |access-date=2023-10-09 |website=STAT |language=en-US}}</ref> Habener was awarded the 2020 [[Warren Alpert Foundation Prize]] along with [[Daniel J. Drucker|Daniel Drucker]] and [[Jens Juul Holst]].<ref>{{Cite web|url=https://warrenalpert.org/prize-recipients|title=Prize Recipients | Warren Alpert Foundation Prize|website=warrenalpert.org}}</ref> He was elected to the [[National Academy of Sciences]] in 2020.<ref>{{Cite web|url=http://www.nasonline.org/news-and-multimedia/news/2020-nas-election.html|title=2020 NAS Election|website=www.nasonline.org}}</ref> In 2021, he was awarded the [[Canada Gairdner International Award]].<ref>[https://gairdner.org/winners/current-winners/ Canada Gairdner International Award 2021]</ref> In 2023, he received the [[VinFuture Prize]].<ref name="2023_VinFuture_Prize_VNE">{{Cite web |last=Nhu |first=Quynh |date=21 December 2023 |title=Battery researchers win $3M Vietnamese awards. |url=https://e.vnexpress.net/news/news/battery-researchers-win-3m-vietnamese-awards-4691489.html |website=[[VnExpress]]}}</ref> In 2024, he was awarded the [[Princess of Asturias Awards]] for Technical and Scientific Research,<ref>[https://www.fpa.es/en/five-world-leaders-in-the-field-of-endocrinology-princess-of-asturias-award-for-technical-and-scientific-research.html Princess of Asturias Awards 2024]</ref> the [[Tang Prize]] in the category of "Biopharmaceutical Science"<ref>[https://www.tang-prize.org/en/media_detail.php?id=1941&cat=24 Tang Prize 2024]</ref> and also in 2024 the [[Lasker Award]]<ref>[https://laskerfoundation.org Albert Lasker Award for Clinical Research]</ref><ref>{{Cite Q|Q130375905}}</ref> for clinical research. |
|||
| ⚫ | |||
{{reflist}} |
|||
| ⚫ | |||
| ⚫ | |||
{{Reflist}} |
|||
{{Princess of Asturias Award for Technical and Scientific Research}} |
|||
| ⚫ | |||
{{DEFAULTSORT:Habener, Joel}} |
|||
[[Category:Harvard Medical School staff]] |
[[Category:Harvard Medical School staff]] |
||
[[Category:Medical researchers]] |
[[Category:Medical researchers]] |
||
| ⚫ | |||
[[Category:Members of the United States National Academy of Sciences]] |
[[Category:Members of the United States National Academy of Sciences]] |
||
| ⚫ | |||
[[Category:Year of birth missing (living people)]] |
|||
{{ |
{{US-physician-stub}} |
||
Latest revision as of 22:06, 6 November 2024
Joel Habener | |
|---|---|
| Alma mater | |
| Occupation | Endocrinologist  |
| Awards |
|
Joel Habener is a Professor of Medicine at Harvard Medical School.
Habener worked with Svetlana Mojsov on elucidating the role of incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2). Habener received credit for the work on hormones when Mosjov was not credited.[1] Habener was awarded the 2020 Warren Alpert Foundation Prize along with Daniel Drucker and Jens Juul Holst.[2] He was elected to the National Academy of Sciences in 2020.[3] In 2021, he was awarded the Canada Gairdner International Award.[4] In 2023, he received the VinFuture Prize.[5] In 2024, he was awarded the Princess of Asturias Awards for Technical and Scientific Research,[6] the Tang Prize in the category of "Biopharmaceutical Science"[7] and also in 2024 the Lasker Award[8][9] for clinical research.
References
[edit]- ^ Molteni, Megan; Chen, Elaine (27 September 2023). "The Ozempic revolution is rooted in the work of Svetlana Mojsov, yet she's been edged out of the story". STAT. Retrieved 2023-10-09.
- ^ "Prize Recipients | Warren Alpert Foundation Prize". warrenalpert.org.
- ^ "2020 NAS Election". www.nasonline.org.
- ^ Canada Gairdner International Award 2021
- ^ Nhu, Quynh (21 December 2023). "Battery researchers win $3M Vietnamese awards". VnExpress.
- ^ Princess of Asturias Awards 2024
- ^ Tang Prize 2024
- ^ Albert Lasker Award for Clinical Research
- ^ Prashant Nair (19 September 2024). "QnAs with Svetlana Mojsov, Joel Habener, and Lotte Bjerre Knudsen: Winners of the 2024 Lasker~DeBakey Clinical Medical Research Award". Proceedings of the National Academy of Sciences of the United States of America. 121 (39). doi:10.1073/PNAS.2416868121. ISSN 0027-8424. Wikidata Q130375905.
| International | |
|---|---|
| National | |
| Other | |
   | This biographical article related to a physician in the United States is a stub. You can help Wikipedia by expanding it. |